These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 7130245
1. Anticoagulant treatment of rats with Walker 256 carcinosarcoma. Owen CA. J Cancer Res Clin Oncol; 1982; 104(1-2):191-3. PubMed ID: 7130245 [Abstract] [Full Text] [Related]
2. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during growth and anticoagulant exposure. An autoradiographic study]. Kolomina SM, Pogodina LS, Chentsov IuS, Kudriashov BA, Vasil'eva TN. Tsitol Genet; 1982; 16(5):68-73. PubMed ID: 7147343 [Abstract] [Full Text] [Related]
3. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during the process of growth and exposure to anticoagulants (an enzyme cytochemical analysis)]. Kolomina SM, Pogodina LS, Chentsov IuS, Kudriashov BA, Vasil'eva TN. Tsitol Genet; 1982; 16(6):18-24. PubMed ID: 7157464 [Abstract] [Full Text] [Related]
4. The rationale of anticoagulants in the treatment of cancer. Cliffton EE, Grossi CE. J Med; 1974; 5(1):107-13. PubMed ID: 4275504 [No Abstract] [Full Text] [Related]
5. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea]. Kolomina SM, Chentsov IuS, Pogodina LS, Kudriashov BA, Kalishevskaia TM. Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204 [No Abstract] [Full Text] [Related]
6. Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats. Torpie RJ. J Med; 1974; 5(1):133-48. PubMed ID: 4524856 [No Abstract] [Full Text] [Related]
7. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra KL, Rodriguez M, Powis G. Cancer Res; 1989 Feb 15; 49(4):977-82. PubMed ID: 2912564 [Abstract] [Full Text] [Related]
8. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R. Semin Thromb Hemost; 2008 Feb 15; 34(1):58-73. PubMed ID: 18393143 [Abstract] [Full Text] [Related]
9. [Effect of heparin complexed with urea on tumor growth and the ultrastructure of malignant cells]. Kudriashov BA, Kolomina SM, Kalishevskaia TM, Pogodina LS, Chentsov IuS. Farmakol Toksikol; 1979 Feb 15; 42(2):147-55. PubMed ID: 437082 [Abstract] [Full Text] [Related]
13. [Effect of heparin on the growth of Walker carcinoma]. Wieser O, Emminger A, Mohr U. Krebsarzt; 1968 Feb 15; 23(3):195-6. PubMed ID: 4174573 [No Abstract] [Full Text] [Related]
16. [The heparin-dependent inhibition of the accumulation of 131J-fibrinogen in the solid form of Walker-256-carcinosarcoma of the rat (author's transl)]. Heyes H, Köhle W. Arch Geschwulstforsch; 1978 Feb 15; 48(8):712-7. PubMed ID: 753192 [Abstract] [Full Text] [Related]
17. Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256. Krempien B, Wingen F, Eichmann T, Müller M, Schmähl D. Oncology; 1988 Feb 15; 45(1):41-6. PubMed ID: 3340393 [Abstract] [Full Text] [Related]